US Patent 8404234 Fixed dosing of HER antibodies
Patent 8404234 was granted and assigned to Genentech on March, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 29 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+97 characters)
Article
Patent abstract
The present invention concerns fixed dosing of HER antibodies, such as Pertuzumab.
Edits on 21 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Chee M. Ng0
David E. Allison0
Jian-Feng Lu0
Rene Bruno0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08404234 Fixed dosing of HER antibodies US Patent 8404234 Fixed dosing of HER antibodies
Infobox
Patent Number
084042340
Patent Number
84042340
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084042340
Date of Patent
March 26, 2013
0Patent Application Number
122482230
Date Filed
October 9, 2008
0Patent Primary Examiner
Edits on 16 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08404234 Fixed dosing of HER antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08404234
Date of patent
March 26, 2013
Patent application number
12248223
Date Filed
October 9, 2008
Patent primary examiner
Find more entities like US Patent 8404234 Fixed dosing of HER antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.